+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis



Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis



Thrombosis and Haemostasis 71(6): 768-772



Rats which were infected with the gram-negative pathogen Klebsiella pneumoniae develop disseminated intravascular coagulation (DIC), multi-organ failure (MOF) and finally die in a septic shock. We investigated the therapeutic effect of antibiotic (tobramycin) treatment combined with the infusion of the highly specific thrombin inhibitor rec. hirudin. Although administration of 2 mg/kg tobramycin alone leads to a decrease of the bacterial burden, DIC could not be prevented. Infusion of rec. hirudin (0.25 mg/kg times h) for 4 h (start of treatment 1 h post infection), in addition to a bolus administration of tobramycin, led to an amelioration of DIC parameters as fibrinogen, thrombin-antithrombin complex (TAT) and platelets. Serum transaminase levels (GOT, GPT) as a marker of MOF were significantly improved by rec. hirudin, the T-50 value increased from 17 h in the tobramycin group to 42 h in the tobramycin + rec. hirudin group, mortality rates were 90% or 60%, respectively. Combination of heparin (100 U/kg times h) and tobramycin was not effective on survival.

(PDF emailed within 1 workday: $29.90)

Accession: 008344006

Download citation: RISBibTeXText

PMID: 7974345


Related references

The effect of the recombinant thrombin inhibitor hirudin on klebsiella pneumoniae induced disseminated intravascular clotting in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 349(SUPPL ): R74, 1994

Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis. Annals of PharmacoTherapy 48(2): 274-278, 2014

Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis. Brazilian Journal of Infectious Diseases 18(5): 574-575, 2015

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin. Thrombosis and Haemostasis 72(3): 381-386, 1994

Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma. Blood Coagulation & Fibrinolysis 6(6): 553-560, 1995

Measurement of thrombin-hirudin complex documents persistent thrombin formation in patients with unstable angina during anticoagulation with recombinant hirudin. Circulation 88(4 PART 2): I319, 1993

Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review. Annals of Clinical Microbiology and Antimicrobials 16(1): 76, 2018

Inhibition of clot-bound and free (fluid-phase thrombin) by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma. Blood Coagulation & Fibrinolysis 5(6): 879-887, 1994

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 79(3): 657-665, 1989

Antibiotic-induced release of inflammatory mediators from bacteria in experimental Klebsiella pneumoniae-induced sepsis. Folia Microbiologica 50(2): 167-171, 2005

Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor. Plastic and Reconstructive Surgery 95(5): 894-900, 1995

Combination of exchange transfusion and directed antibiotic therapy in the treatment of severe sepsis. A case of multi-resistant Serratia marcescens sepsis. Minerva Pediatrica 30(9): 753-757, 1978

Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin. Protein Expression and Purification 8(2): 167-174, 1996

Inhibition of clot-bound and free by a novel synthetic thrombin inhibitor , recombinant hirudin and heparin in human plasma. Blood Coagulation & Fibrinolysis 5(6): 879-887, 1994

Chemical modifications and amino acid substitutions in recombinant hirudin that increase hirudin-thrombin affinity. Biochemistry 30(5): 1271-1277, 1991